Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 220

Posts Tagged ‘apollo.’

31st Annual Piper Jaffray Healthcare Conference

Posted by fidest press agency su giovedì, 28 novembre 2019

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that company management will present at the 31st Annual Piper Jaffray Healthcare Conference at the Lotte New York Palace in New York, NY on December 5, 2019. The presentation is scheduled for 1:00 pm Eastern Time.
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo’s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo’s products are offered in over 80 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon. Apollo’s common stock is traded on Nasdaq Global Market under the symbol “APEN”. For more information regarding Apollo Endosurgery, go to: http://www.apolloendo.com.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Apollo Endosurgery Announces Spanish Study of ESG in NASH Patients

Posted by fidest press agency su mercoledì, 16 maggio 2018

Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the enrollment of the first patient in a multicenter, randomized, controlled, double-blind study of the efficacy and safety of Endoscopic Sleeve Gastroplasty (“ESG”) using Apollo’s OverStitch™ Endoscopic Suturing System, in patients with non-alcoholic steatohepatitis (“NASH”). The study is funded by a Beca FIS Grant awarded to the Foundation of the Hospital Universitario Puerta de Hierro Majadahonda by the Ministry of Health of the Spanish Government. The study will involve four National Health System Hospitals, led by Professor José Luis Calleja, MD from Hospital Universitario Puerta de Hierro Majadahonda – Universidad Autónoma de Madrid, as Principal Investigator. The primary objective of the study is to compare the efficacy of ESG plus lifestyle modification to lifestyle modification alone in the resolution of NASH without worsening of fibrosis in patients with BMI greater than 30 kg/m2.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Verallia: Saint gobain vende ad Apollo il terzo produttore mondiale di packaging in vetro per F&B

Posted by fidest press agency su domenica, 1 novembre 2015

Saint-Gobain ha annunciato di aver concluso in data odierna la finalizzazione (closing) della cessione di Verallia ad Apollo Global Management LLC e Bpifrance, che ora ne detengono rispettivamente il 90% e il 10% del capitale.Con i nuovi soci, Verallia è diventato un Gruppo industriale completamente autonomo, interamente dedicato all’imballaggio in vetro. Si apre dunque un nuovo capitolo nella lunga storia dell’azienda, che dal 1827 ha sviluppato il suo know-how nel campo del vetro e negli anni ha rafforzato le proprie attività industriali e commerciali con nuovi insediamenti in Europa occidentale, Europa orientale, America del sud e Africa del nord. Il Gruppo, la cui sede sociale resta in Francia, conta oggi su quasi 10.000 collaboratori al servizio di oltre 10.000 clienti nel mondo. Verallia è un leader mondiale sul mercato dei vini, degli alcolici e dei prodotti alimentari ed è anche un importante operatore nel segmento della birra in numerosi paesi come la Germania e il Brasile.

Posted in Cronaca/News, Economia/Economy/finance/business/technology | Contrassegnato da tag: , , , | Leave a Comment »